<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-12T08:12:17+00:00">
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-NPL-Z-MOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>The Ministry of Health and Population battles against the burden of three disease with the support of its community - Nepal (01-Feb-2025-15-Jul-2027)</narrative>
    </title>
    <description type="1">
      <narrative>Nepal, Multicomponent, Ministry of Health and Food Safety of Nepal</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate Nepal's HIV response to achieve zero new infections, zero AIDS-related deaths, and eliminate HIV inequalities by 2030, as per NHSP 2021-2026; Nepal has set a goal to decrease incidence rate from 238 in 2020/21 to 181 per 100,000 population by 2025/26; decrease mortality rate from 58 in 2020/21 to 23 per 100,000 by 2025/26; end TB epidemic by 2035; eliminate TB by 2050; and reduce the catastrophic cost to zero; Reduce the indigenous malaria cases to zero by 2026 and sustain thereafter; Sustain zero malaria mortality. Objectives: Increase access to people-centered services across the HIV prevention and care continuum; Optimize health outcomes for people living with HIV and key populations; Strengthen community and health system resilience to reduce barriers to HIV prevention, treatment and care; To build and strengthen political commitment, sustainability and patient-friendly health system to end TB; To ensure the identification of TB, diagnosis, quality treatment and prevention; To ensure proportional and equitable access to quality assured diagnosis and treatment in health facilities as per federal structure and implement effective preventive measures to achieve malaria elimination.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Food Safety of Nepal</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Food Safety of Nepal</narrative>
    </participating-org>
    <other-identifier ref="NPL-Z-MOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-02-01" />
    <activity-date type="2" iso-date="2025-02-01" />
    <activity-date type="3" iso-date="2027-07-15" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Manab Basnet</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>manab.basnet@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="NP" percentage="100">
      <narrative>Nepal</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="64.78">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12262" percentage="21.77">
      <narrative>Malaria</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="7.81">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="5.64">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="3.44">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.39">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="3.74">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="738953d0-45d2-486f-957e-e3fee8de75cd" percentage="4.27">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Facility-based treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="c0797acd-77a1-43ee-9c39-6bf17fd6f4ed" percentage="9.52">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Integrated community case management (iCCM)</narrative>
        </description>
      </budget-item>
      <budget-item code="59cc9679-08ba-48b1-90fb-371a75703026" percentage="4.89">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Intensified activities for elimination</narrative>
        </description>
      </budget-item>
      <budget-item code="542041a9-b20c-4180-b95d-9e42a05de9f3" percentage="0.78">
        <description>
          <narrative>Malaria -&gt; Case management -&gt; Therapeutic efficacy surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="09ec106d-6825-4ae2-a0ad-18a0f9f53a64" percentage="2.08">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Entomological monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="8a9aef0d-fc01-47c9-bc48-61216a92e266" percentage="0.11">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Indoor residual spraying (IRS)</narrative>
        </description>
      </budget-item>
      <budget-item code="0904e74b-3fd7-4544-bb4e-8343228bdbe5" percentage="0.12">
        <description>
          <narrative>Malaria -&gt; Vector control -&gt; Insecticide treated nets (ITNs) - Mass campaign: universal</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="21.33">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="4.92">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="57ef74d8-840a-4792-b7d8-0c12163d7d91" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
        </description>
      </budget-item>
      <budget-item code="f9c0078b-d557-4047-b352-b4b2eba7e5b8" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory Information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="12.31">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="12.2">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="1.92">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="0.45">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="9047155e-4a95-4897-b0bd-857d3f703670" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Routine financial management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="167f27b6-c3cb-4dfb-96ff-0d8fca05baf8" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Social contracting</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="38ed2119-0193-4f73-9333-90fbd5a8cc0b" percentage="0.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Supply chain information systems</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="2.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="2.94">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="178ad552-8e84-49d7-8952-4e30d00c6364" percentage="3.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; RSSH/PP: Surveillance for priority epidemic-prone diseases and events</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="1.35">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="85fbea77-53b5-4647-bd23-d3053191c7bb" percentage="0.36">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveillance for HIV, tuberculosis and malaria</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.4">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0.11">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.71">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.47">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="897b3d08-9a6f-4d26-89e2-f762e49dad11" percentage="3.44">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Preventive treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.36">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.06">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1384957.15</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">1524243.95</value>
    </budget>
    <capital-spend percentage="0.2" />
    <transaction ref="3956f8bb-c74e-48d9-bd3b-24fdf730bea9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-04" />
      <value currency="USD" value-date="2025-09-04">1594859.00</value>
      <description>
        <narrative>Global Fund commitment to NPL-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="02bb1505-2333-44b9-8c91-48d9703f5d95">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-09-09" />
      <value currency="USD" value-date="2025-09-09">410459.00</value>
      <description>
        <narrative>Global Fund disbursement to NPL-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7a2f8067-cbd3-4b71-b32f-9da5df09bf81">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-20" />
      <value currency="USD" value-date="2026-01-20">390000.00</value>
      <description>
        <narrative>Global Fund disbursement to NPL-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d46d556e-b2c1-4f52-adad-1e67ab65da82">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">794400.00</value>
      <description>
        <narrative>Global Fund disbursement to NPL-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ab6e4b67-0fb6-4bde-acf0-5723bc8773d4">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-03" />
      <value currency="USD" value-date="2026-11-03">765119.00</value>
      <description>
        <narrative>Global Fund commitment to NPL-Z-MOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aa8fdcc7-fe79-4b1d-83aa-5d634661a8d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">765119.00</value>
      <description>
        <narrative>Global Fund disbursement to NPL-Z-MOHP01 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Food Safety of Nepal</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/NPL-Z-MOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NPL/2024/Tuberculosis/en/NPL-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - Tuberculosis - Nepal - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1426-NPL-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NPL/2023/Malaria/en/NPL-M_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 3 - Malaria - Nepal - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1427-NPL-M.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-08-21" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/NPL/2024/HIV/en/NPL-H_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 5 - HIV - Nepal - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1425-NPL-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-04-29" />
    </document-link>
    <conditions attached="1">
      <condition type="2">
        <narrative>1 - Training Plan Prior to the use of Grant Funds by the Principal Recipient to finance training and other types of learning and studying, either in Nepal or abroad, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s written approval of, a Training Plan describing the topic of training, the recipients, the expected added value and the specific cost.</narrative>
      </condition>
      <condition type="2">
        <narrative>2 - Value Added Tax (“VAT”) Waiver By no later than 1 February 2025, the Principal Recipient shall submit to the Global Fund, and obtain the Global Fund’s prior written approval of, the Principal Recipient’s VAT waiver policy. The Grantee acknowledges and agrees, pursuant to Section 3.5 of the Global Fund Grant Regulations (as amended from time to time), that VAT shall not be applied on the NPL-Z-MOH and NPL-Z-UNDP grants.</narrative>
      </condition>
      <condition type="3">
        <narrative>3 - (1) Grant Funds may be used to pay for the services of an external auditor. In the case of the Principal Recipient, being the Ministry of Health and Population, the Office of the Auditor General (“OAG”) of Nepal will ensure that a Global Fund-specific audit is planned under the ‘Project Financial Statement Audit Directives,’ introduced in 2023 with the support of the World Bank. This directive provides a clear structure for focused audits on specific projects, including those funded by the Global Fund; (2) the Principal Recipient consents to the carrying out of audits of the Program by the OAG for the period covering fiscal years 2025, 2026, 2027 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing) and to the terms of reference of the Auditor and agrees that such terms of reference may be amended from time to time. For the avoidance of doubt, the audit will also cover the 1 February 2025 – 30 June 2025 period despite the off-fiscal year status; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the Auditor to allow them to perform its services, including by providing all information and documents requested by the Auditor or the Global Fund.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of confirmed cases fully investigated and classified as per national guidance</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of confirmed cases fully investigated and classified as per national guidance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="88.12">
          <comment>
            <narrative>Numerator: 586; Denominator: 665.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 370; Denominator: 370.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 445; Denominator: 445.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 872; Denominator: 872.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 427; Denominator: 427.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 427; Denominator: 427.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 466; Denominator: 466.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of districts achieving national target for the proportion of confirmed malaria patients who received first-line antimalarial treatment</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of districts achieving national target for the proportion of confirmed malaria patients who received first-line antimalarial treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 60; Denominator: 60.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 58; Denominator: 58.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 58; Denominator: 58.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 114; Denominator: 114.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 56; Denominator: 56.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 56; Denominator: 56.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 55; Denominator: 55.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of districts achieving national target for the proportion of suspected malaria patients who receive a parasitological test</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of districts achieving national target for the proportion of suspected malaria patients who receive a parasitological test</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="27.27">
          <comment>
            <narrative>Numerator: 21; Denominator: 77.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="45.45">
            <comment>
              <narrative>Numerator: 35; Denominator: 77.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="51.9">
            <comment>
              <narrative>Numerator: 80; Denominator: 154.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="45.45">
            <comment>
              <narrative>Numerator: 35; Denominator: 77.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="58.44">
            <comment>
              <narrative>Numerator: 45; Denominator: 77.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="58.44">
            <comment>
              <narrative>Numerator: 45; Denominator: 77.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="71.43">
            <comment>
              <narrative>Numerator: 55; Denominator: 77.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of malaria foci fully investigated and classified as per the national guidance</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of malaria foci fully investigated and classified as per the national guidance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 16; Denominator: 16; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 4; Denominator: 4; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 5; Denominator: 5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 5; Denominator: 5; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at private sector sites</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 94; Denominator: 94; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 16; Denominator: 16; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 570; Denominator: 649; Percentage: 87.83%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 55; Denominator: 55; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 66; Denominator: 66; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 130; Denominator: 130; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 64; Denominator: 64; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 40; Denominator: 40; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 64; Denominator: 64; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 69; Denominator: 69; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 542; Denominator: 542.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 28; Denominator: 28.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1; Denominator: 1.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 296.25; Denominator: 296.25.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 355.5; Denominator: 355.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 693.5; Denominator: 693.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 338; Denominator: 338.</narrative>
            </comment>
          </target>
          <actual value="100">
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 458; Denominator: 458.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 338; Denominator: 338.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 371; Denominator: 371.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of confirmed malaria cases that received first-line antimalarial treatment in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 29; Denominator: 29; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="5+" />
          <comment>
            <narrative>Numerator: 93; Denominator: 93; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 1; Denominator: 1; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 20; Denominator: 20; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 49; Denominator: 49; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 25; Denominator: 25; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Age" value="5+" />
            <comment>
              <narrative>Numerator: 13; Denominator: 13; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 25; Denominator: 25; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 26; Denominator: 26; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at private sector sites</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 122998; Denominator: 122998; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 2; Denominator: 2; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 81489; Denominator: 81489; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 97786.81; Denominator: 97786.81; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 175166.9; Denominator: 175166.9; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 77380.15; Denominator: 77380.15; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 33432.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 116070.22; Denominator: 116070.22; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 111575.05; Denominator: 111575.05; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test at public sector health facilities</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 278546; Denominator: 278546; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 66440; Denominator: 66440; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 203261.2; Denominator: 203261.2; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 442094.6; Denominator: 442094.6; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 243913.44; Denominator: 243913.44; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 198181.16; Denominator: 198181.16; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 89227.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 297271.74; Denominator: 297271.74; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 293520.47; Denominator: 293520.47; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
      </title>
      <description>
        <narrative>Module: Case management.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Proportion of suspected malaria cases that receive a parasitological test in the community</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 66440; Denominator: 66440; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Testing type" value="Microscopy" />
          <comment>
            <narrative>Numerator: 43049.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Testing type" value="Rapid diagnostic test" />
          <comment>
            <narrative>Numerator: 79949; Denominator: 79949; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 39146.16; Denominator: 39146.16; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 46975.39; Denominator: 46975.39; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 85215.3; Denominator: 85215.3; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 38239.85; Denominator: 38239.85; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Testing type" value="Microscopy" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Testing type" value="Rapid diagnostic test" />
            <comment>
              <narrative>Numerator: 16122.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 57359.78; Denominator: 57359.78; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 56741.34; Denominator: 56741.34; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="94.01">
          <comment>
            <narrative>Numerator: 2416; Denominator: 2570.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="95">
            <comment>
              <narrative>Numerator: 841; Denominator: 885.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 841; Denominator: 885.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 841; Denominator: 885.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="95.04">
            <comment>
              <narrative>Numerator: 652; Denominator: 686.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="693" />
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="468" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="1223" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="601" />
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="622" />
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="860" />
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="860" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="78.79">
          <comment>
            <narrative>Numerator: 546; Denominator: 693.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="85.04">
            <comment>
              <narrative>Numerator: 398; Denominator: 468.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="87.5">
            <comment>
              <narrative>Numerator: 1070; Denominator: 1223.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="84.86">
            <comment>
              <narrative>Numerator: 510; Denominator: 601.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="90.03">
            <comment>
              <narrative>Numerator: 560; Denominator: 622.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="90">
            <comment>
              <narrative>Numerator: 774; Denominator: 860.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="90">
            <comment>
              <narrative>Numerator: 774; Denominator: 860.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="77.02">
          <comment>
            <narrative>Numerator: 305; Denominator: 396.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="82.05">
            <comment>
              <narrative>Numerator: 224; Denominator: 273.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="82.08">
            <comment>
              <narrative>Numerator: 229; Denominator: 279.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="83.6">
            <comment>
              <narrative>Numerator: 493; Denominator: 590.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="84.89">
            <comment>
              <narrative>Numerator: 264; Denominator: 311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="85.07">
            <comment>
              <narrative>Numerator: 285; Denominator: 335.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="85.07">
            <comment>
              <narrative>Numerator: 285; Denominator: 335.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
      </title>
      <description>
        <narrative>Module: Elimination of vertical transmission of HIV, syphilis and hepatitis B.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 2037.07.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 27063.93.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 153; Denominator: 214; Percentage: 71.5%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 83; Denominator: 190; Percentage: 43.68%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 83; Denominator: 190; Percentage: 43.68%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 169; Denominator: 181; Percentage: 93.4%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 86; Denominator: 181; Percentage: 47.51%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 63.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 86; Denominator: 181; Percentage: 47.51%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 82; Denominator: 172; Percentage: 47.67%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories accredited according to ISO15189 standard or achieving at least four stars towards accreditation or two-star incremental improvement</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="16.67">
          <comment>
            <narrative>Numerator: 1; Denominator: 6.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 1; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="33.33">
            <comment>
              <narrative>Numerator: 2; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="50">
            <comment>
              <narrative>Numerator: 3; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="66.67">
            <comment>
              <narrative>Numerator: 4; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 6; Denominator: 6.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of molecular diagnostic analyzers achieving at least 85% functionality (ability to test samples) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="89.66">
          <comment>
            <narrative>Numerator: 130; Denominator: 145.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="89.66">
            <comment>
              <narrative>Numerator: 130; Denominator: 145.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="90">
            <comment>
              <narrative>Numerator: 135; Denominator: 150.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="95">
            <comment>
              <narrative>Numerator: 508; Denominator: 535.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="94.95">
            <comment>
              <narrative>Numerator: 508; Denominator: 535.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="94.95">
            <comment>
              <narrative>Numerator: 508; Denominator: 535.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="94.95">
            <comment>
              <narrative>Numerator: 508; Denominator: 535.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Completeness of reporting: Percentage of expected monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="89" />
        <baseline year="2024" iso-date="2024-12-31" value="100">
          <comment>
            <narrative>Numerator: 172; Denominator: 172.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="100" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Timeliness of reporting: Percentage of submitted monthly reports (for the reporting period) that are received on time per the national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="81" />
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="95" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="100" />
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 27063.93.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 27729; Denominator: 30125; Percentage: 92.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 1372; Denominator: 3347; Percentage: 40.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 2037.07.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 40128.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 22181.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 47997.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 23907.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 24090.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 20230.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 13175.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 20712.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 774.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 26103.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 26103.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="51">
          <comment>
            <narrative>Numerator: 11947; Denominator: 23425.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="60">
            <comment>
              <narrative>Numerator: 13309; Denominator: 22181.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="65">
            <comment>
              <narrative>Numerator: 15540; Denominator: 23907.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="65">
            <comment>
              <narrative>Numerator: 31199; Denominator: 47997.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="65">
            <comment>
              <narrative>Numerator: 15659; Denominator: 24090.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="70">
            <comment>
              <narrative>Numerator: 18272; Denominator: 26103.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="70">
            <comment>
              <narrative>Numerator: 18272; Denominator: 26103.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- private/non-governmental facilities; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 51835.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 10963; Denominator: 40126; Percentage: 27.32%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 6654; Denominator: 22181; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 7172; Denominator: 23907; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 14399; Denominator: 47997; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 7227; Denominator: 24090; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2060.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 7831; Denominator: 26103; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 7831; Denominator: 26103; Percentage: 30%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="92.99">
          <comment>
            <narrative>Numerator: 34410; Denominator: 37003.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 21863; Denominator: 23764.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 41555; Denominator: 45169.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 21149; Denominator: 22988.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 20406; Denominator: 22181.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 21995; Denominator: 23907.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="92">
            <comment>
              <narrative>Numerator: 22163; Denominator: 24090.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="4737" />
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="10646" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="11465" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="14036" />
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="2571" />
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="2829" />
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="2829" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="98.56">
          <comment>
            <narrative>Numerator: 205; Denominator: 208.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="98.03">
            <comment>
              <narrative>Numerator: 249; Denominator: 254.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="98.02">
            <comment>
              <narrative>Numerator: 247; Denominator: 252.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="98.1">
            <comment>
              <narrative>Numerator: 508; Denominator: 518.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="98.12">
            <comment>
              <narrative>Numerator: 261; Denominator: 266.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="98">
            <comment>
              <narrative>Numerator: 258.72; Denominator: 264.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="98.11">
            <comment>
              <narrative>Numerator: 259; Denominator: 264.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 5513; Denominator: 22421; Percentage: 24.59%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 7576; Denominator: 25728; Percentage: 29.45%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 10443; Denominator: 26374; Percentage: 39.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 11903; Denominator: 26704; Percentage: 44.57%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 25336; Denominator: 27039; Percentage: 93.7%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 13433; Denominator: 27039; Percentage: 49.68%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 11824.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 14963; Denominator: 27375; Percentage: 54.66%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 16348; Denominator: 27381; Percentage: 59.71%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 430237.14.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 36285.06.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 51835.8.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 1500; Denominator: 1500; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1092.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 20.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 682.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="90">
          <comment>
            <narrative>Numerator: 33192.9; Denominator: 36881.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="95">
            <comment>
              <narrative>Numerator: 31688; Denominator: 33356.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="97.5">
            <comment>
              <narrative>Numerator: 64736; Denominator: 66396.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="95">
            <comment>
              <narrative>Numerator: 31545; Denominator: 33205.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 33191; Denominator: 33191.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 33041; Denominator: 33041.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="100">
            <comment>
              <narrative>Numerator: 33041; Denominator: 33041.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 7004.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 18245.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 945; Denominator: 1097; Percentage: 86.14%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 945; Denominator: 1018; Percentage: 92.83%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 932; Denominator: 972; Percentage: 95.9%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 953; Denominator: 1018; Percentage: 93.61%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 932; Denominator: 972; Percentage: 95.88%.</narrative>
            </comment>
          </target>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 352; Denominator: 490; Percentage: 71.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 407; Denominator: 512; Percentage: 79.49%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target>
            <comment>
              <narrative>Numerator: 910; Denominator: 972; Percentage: 93.62%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target>
            <comment>
              <narrative>Numerator: 890; Denominator: 923; Percentage: 96.42%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="23.41">
          <comment>
            <narrative>Numerator: 6024; Denominator: 25728.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="28">
            <comment>
              <narrative>Numerator: 7578; Denominator: 27039.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="28.03">
            <comment>
              <narrative>Numerator: 7578; Denominator: 27039.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="30">
            <comment>
              <narrative>Numerator: 8212; Denominator: 27375.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="35.01">
            <comment>
              <narrative>Numerator: 9586; Denominator: 27381.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="84.91">
          <comment>
            <narrative>Numerator: 25728; Denominator: 30302.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="87.01">
            <comment>
              <narrative>Numerator: 26374; Denominator: 30311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="89.1">
            <comment>
              <narrative>Numerator: 27039; Denominator: 30332.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="88.1">
            <comment>
              <narrative>Numerator: 26704; Denominator: 30311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="89.14">
            <comment>
              <narrative>Numerator: 27039; Denominator: 30332.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="90.25">
            <comment>
              <narrative>Numerator: 27375; Denominator: 30332.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="90.23">
            <comment>
              <narrative>Numerator: 27381; Denominator: 30347.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="77.1">
          <comment>
            <narrative>Numerator: 165; Denominator: 214.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="90.53">
            <comment>
              <narrative>Numerator: 86; Denominator: 95.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="190.1">
            <comment>
              <narrative>Numerator: 172; Denominator: 90.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="90.53">
            <comment>
              <narrative>Numerator: 86; Denominator: 95.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 86; Denominator: 90.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="95.03">
            <comment>
              <narrative>Numerator: 86; Denominator: 90.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="95.35">
            <comment>
              <narrative>Numerator: 82; Denominator: 86.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to populations at risk of malaria transmission through mass campaigns</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="47953" />
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="15566.41" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="18679.69" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="26532.2" />
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="7852.46" />
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="7852.46" />
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="119096.4" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
      </title>
      <description>
        <narrative>Module: Vector control.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of insecticide-treated nets distributed to targeted risk groups through continuous distribution</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="18635" />
        <period>
          <period-start iso-date="2025-02-01" />
          <period-end iso-date="2025-07-15" />
          <target value="2350.21" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-01-15" />
          <target value="2820.25" />
        </period>
        <period>
          <period-start iso-date="2025-07-16" />
          <period-end iso-date="2026-07-15" />
          <target value="6396.5" />
        </period>
        <period>
          <period-start iso-date="2026-01-16" />
          <period-end iso-date="2026-07-15" />
          <target value="3576.22" />
        </period>
        <period>
          <period-start iso-date="2026-07-16" />
          <period-end iso-date="2027-01-15" />
          <target value="3576.22" />
        </period>
        <period>
          <period-start iso-date="2027-01-16" />
          <period-end iso-date="2027-07-15" />
          <target value="8376.03" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>